Nuclear Medicine & Radiation Therapy

Lukman Tijani

Publications

• Research Article
  A Prospective Pilot Study of Single 19 Gy Fraction High-Dose-Rate Brachytherapy for Favorable-Risk Adenocarcinoma of the Prostate
  Author(s): Scott Dahlbeck, Chase C. Hansen, Werner deRiese, Robert Kagan A, Carlos Torres, Maurizio Chiriva-Internati D, Everardo Cobos, Jose A. Figueroa, Diane Nguyen, Lukman Tijani and Jaden D. EvansScott Dahlbeck, Chase C. Hansen, Werner deRiese, Robert Kagan A, Carlos Torres, Maurizio Chiriva-Internati D, Everardo Cobos, Jose A. Figueroa, Diane Nguyen, Lukman Tijani and Jaden D. Evans
  
  Objective: To evaluate the acute genitourinary (GU) and gastrointestinal (GI) toxicities, health-related quality of life (HRQOL) factors, biochemical control rates, and technical feasibility of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer delivered in a single fraction. Methods: A single-institution, prospective pilot study evaluating 6 patients with low- and intermediate-risk prostate cancer treated in 2013. Patients received a single 19 Gy fraction as HDR monotherapy. Patients were assessed according to the Common Terminology Criteria for Adverse Events version 4.0, the International Index of Erectile Function (IIEF-5), the International Prostate Symptom Score (IPSS), the Expanded Prostate Cancer Index Composite–Bowel Assessment (EPIC-Bowel), a Quality of Life (QOL) Assessment, and an in.. Read More»
  DOI: 10.4172/2155-9619.1000215

  Abstract PDF